|
|
Volumn 28, Issue 25, 2010, Pages
|
|
ABCC2 and clinical outcome of tamoxifen therapy
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHENODEOXYCHOLIC ACID;
CYTOCHROME P450 2D6;
DNA;
MULTIDRUG RESISTANCE PROTEIN 2;
TAMOXIFEN;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
MULTIDRUG RESISTANCE PROTEIN;
MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2;
ALLELE;
BREAST CANCER;
CANCER CELL;
CANCER RECURRENCE;
CANCER SURVIVAL;
CELL STRAIN MCF 7;
CHOLESTATIC HEPATITIS;
DNA POLYMORPHISM;
DNA SEQUENCE;
GENETIC VARIABILITY;
HAPLOTYPE;
HUMAN;
LETTER;
OUTCOME ASSESSMENT;
PHARMACOGENOMICS;
POSTMENOPAUSE;
PRIORITY JOURNAL;
ADJUVANT CHEMOTHERAPY;
BREAST TUMOR;
GENETICS;
NOTE;
PROMOTER REGION;
SINGLE NUCLEOTIDE POLYMORPHISM;
ANTINEOPLASTIC AGENTS, HORMONAL;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
HUMANS;
MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS;
POLYMORPHISM, SINGLE NUCLEOTIDE;
PROMOTER REGIONS, GENETIC;
TAMOXIFEN;
|
|
EID: 77957608040
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2010.29.6665 Document Type: Letter |
|
Times cited : (3)
|
|
References (5)
|
